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ABSTRACT
Objective: To identify factors related to the occurrence of urinary tract infection associated 
with urinary catheter use. Method: A longitudinal, retrospective cohort study carried out 
by analyzing the electronic medical records of patients admitted to an intensive care unit 
of a high-complexity hospital from July 2016 to June 2017. Demographic and clinical 
data were analyzed by descriptive and analytical analysis. Results: The incidence density 
of urinary tract infection related to urinary catheter use was 4.8 per 1000 catheters/day, 
the majority (80.6%) with no indication for catheter use, and there was no prescription 
for insertion and/or maintenance in 86.7%. The mean time between catheter insertion 
and infection diagnosis was 11.3 ± 6.3 days (6 to 28 days). Statistically significant factors 
(p < 0.001) related to urinary infection linked to catheter use were hospitalization time 
in the unit (16.7 ± 9 days), catheter permanence time (12.7 ± 6.9 days), and the use of 
antimicrobials in the intensive care unit (8.6 ± 6.3 days). Conclusion: The association of 
indication absence and the record of the need for maintenance possibly potentiated the 
occurrence of urinary tract infection associated to catheter use.
DESCRIPTORS
Urinary Catheters; Catheter-Related Infections; Patient Safety; Infection Control.
Catheter-associated urinary tract infection: why 
do not we control this adverse event?
Infecção do trato urinário associada a cateter vesical: por 
que não controlamos esse evento adverso?
Infección del tracto urinario asociada con catéter vesical: 
¿por qué no controlamos ese evento adverso?
How to cite this article:
Mota EC, Oliveira AC. Catheter-associated urinary tract infection: why do not we control this adverse event? Rev Esc Enferm USP. 2019;53:e03452. DOI: 
http://dx.doi.org/10.1590/S1980-220X2018007503452
Received: 03/14/2018
Approved: 08/27/2018
Corresponding author:
Écila Campos Mota
Av. Corinto Crisóstomo Freire, 600, Apto. 
207, Bloco Hortênsias, Morada do Parque
CEP 39401-365 – Montes Claros, MG, Brazil
ecilacampos@hotmail.com
ORIGINAL ARTICLE DOI: http://dx.doi.org/10.1590/S1980-220X2018007503452
2 www.ee.usp.br/reeusp
Catheter-associated urinary tract infection: why do not we control this adverse event
Rev Esc Enferm USP · 2019;53:e03452
INTRODUCTION
Urinary tract infection (UTI) is one of the most preva-
lent health care-related infections, accounting for approxi-
mately 30% of intensive care unit (ICU) reports because 
of its relationship to urinary catheterization, but has great 
preventive potential(1-3). 
Approximately 80% of healthcare-related UTIs are 
associated with urinary catheter (UC) use. The risk of 
developing a catheter-associated UTI (CAUTI) increases 
with the duration of catheterization, and may reach 5% 
with each day of use. Thus, it is estimated that this risk 
rises to 100% after 28 days of catheterization, culminat-
ing in approximately 4% of patients with evolution from 
secondary sepsis to infection and an estimated mortality 
rate of up to 30%(3-4).
Several strategies to prevent the occurrence of CAUTI 
have been considered, all of which point to a fundamen-
tal principle: restricted indication, performed according to 
guideline recommendations, insertion with aseptic tech-
nique, care in maintenance and rigor regarding the perma-
nence time of the UC(2,5-8). Despite these recommendations, 
UC use is still considered variable with little or no control, 
thereby affecting high CAUTI rates, presenting important 
morbidity and mortality, increased hospitalization time and 
hospital costs(1,5-6).
Subjectivity in the indication and keeping it longer 
than necessary have been described in clinical practice and 
strongly contribute to the occurrence of CAUTI, which 
can be considered avoidable adverse events. Thus, it is 
necessary to identify the gaps in this practice to improve 
the practice regarding use of urinary catheters and their 
occurrence in order to carry out timely interventions and 
modified habits of professionals and expectations about the 
need for a urinary catheter. It is also necessary to reinforce 
the importance of multidisciplinary communication in a 
continuous and consistent manner. Catheter indication 
should be an activity of the attending physician, but must 
be known by all care staff. Its maintenance involves partici-
pation by a multidisciplinary team to collaborate with the 
medical team to evaluate the necessity of their permanence, 
thus guaranteeing the safety of the patient, the team and 
the institution(6).
In view of the aforementioned, this study aimed to iden-
tify the factors related to the occurrence of CAUTI.
METHOD
Study deSign
An epidemiological, longitudinal, retrospective 
cohort study.
Study Scenario
The study was carried out in an ICU for adult patients 
of a high-complexity philanthropic hospital with 321 beds, 
and 80% of the services performed by the Unified Health 
System (SUS – Sistema Único de Saúde) in the state of 
Minas Gerais. The ICU is composed of 10 beds, with a 
monthly average of 36 admissions and an average stay time 
of 8.6 days. Approximately 95% of patients admitted to 
the unit used UC. 
Selection criteria
Patients with UC for more than 24 hours, older than 
18 years and had no diagnosis of UTI upon admission 
were included. 
data collection
Data collection was by convenience sampling from July 
to September 2017 and was carried out by the researcher 
(who has extensive experience in the diagnostic criteria of 
CAUTI) through a retrospective analysis of the electronic 
medical record. The medical and statistical file of the hos-
pital was requested to access all medical records of patients 
admitted to the ICU from July 2016 to June 2017, and 
included patients with UC for more than 24 hours, older 
than 18 years old, and who did not have a UTI diagnosis 
at admission.
A semi-structured instrument was used to evaluate 
demographic data such as gender and age, as well as clini-
cal data such as treatment specialization upon admission, 
indication of UC use, permanence length of UC, CAUTI 
diagnosis, use of antimicrobials during hospitalization 
in the unit, isolated microorganisms in the urinalysis 
and sensitivity profile, hospitalization time in the unit 
and in the hospital, and the outcome (discharge, transfer 
or death). 
The criteria implemented to define CAUTI was from 
the National Healthcare Safety Network (NHSN), which 
consists in(9): patients undergoing catheterization for more 
than 48 hours or after catheter removal within 48 hours, 
fever (≥38 °C) and positive urinalysis with no more than two 
species of microorganisms with growth ≥105 colony forming 
units per ml of urine (CFU/ ml). 
Adequate indications for UC insertion were those 
described by the Centers for Disease Control and 
Prevention (CDC), according to which patients with acute 
urinary retention or bladder obstruction should undergo 
the procedure; in surgeries in which diuresis control is nec-
essary; in the postoperative period of urological surgeries 
up to 24 to 48 hours and long-term surgeries; submitted 
to urological surgeries or involving structures contigu-
ous to the genitourinary tract; incontinent with sacral or 
perineal ulcers; terminal patients, to provide comfort; and 
those with a long period of bed rest due to trauma to the 
spine, waist or pelvis(2). The registered indications (descrip-
tion of the catheterization reason in the patient’s chart) or 
presumed (when it is possible to evaluate the reason for 
catheterization by clinical data and the patient’s diagnosis 
even without registration). 
For the evaluation of microorganisms isolated in uri-
nalysis, only those that were epidemiologically important 
were considered according to the Clinical and Laboratory 
Standards Institute (CLSI)(10).
The calculation of the CAUTI incidence density was per-
formed by the following formula, according to the NHSN(9):
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CAUTI incidence density =
 Total number of CAUTI,in the surveillance periodNumber of patients with UC-day,in the surveillance period ×1000
data analySiS and proceSSing
Descriptive analysis of the data, Pearson’s chi-square test 
or Fisher’s exact test and Mann-Whitney test were per-
formed in the Statistical Package for Social Sciences (SPSS), 
version 23.0. 
ethical aSpectS 
The research complied with all the recommendations of 
Resolution no. 466/2012 of the National Health Council 
and was approved by the Research Ethics Committee of 
the Federal University of Minas Gerais under opinion 
2.069.140/2017. A clear and Informed Consent Form 
was not necessary as it was a survey of secondary data and 
because the access was in electronic medical records (without 
direct contact with the patient). 
RESULTS
There were 432 patients admitted to the ICU during 
follow-up; of these, 402 (93.3%) used UC for more than 24 
hours, thereby constituting the study sample. The mean age 
of the patients was 50.6 years (median 50), with a standard 
deviation of ± 18.8, and 56.7% were male. The mean hospi-
talization time of patients in the hospital and ICU was 30 
and 8.6 days, respectively.
The majority of patients admitted to the ICU came from 
the emergency room (43.8%) for surgical (56.2%) and/or 
clinical (43.8%) specializations. The surgical specialization 
with the greatest number of hospitalizations was neurologi-
cal surgery (52.2%), and general clinical (52.2%). Moreover, 
87.3% of the patients used antimicrobials during ICU stay 
to treat infections not associated with the objective of this 
study for an average of 5.3 days. Regarding the evolution, 
60.2% were transferred to semi-intensive units or infirma-
ries, 35.8% evolved to death, and 4% were discharged from 
hospital. Table 1 shows the characteristics related to the use 
of UC in the ICU. 
No registry of catheter replacement or reintegration into 
ICU admission was observed, even if inserted in another 
location outside the hospital units. 
The site which presented the highest non-conformity 
index regarding the appropriate indication for UC inser-
tion was the infirmary (94.3%). All the indications con-
sidered adequate for UC use in patients admitted to the 
ICU were presumed, and most were not prescribed. Only 
four (7.7%) of the prescribed catheters were presumably 
adequate. 
The number of patients with catheter/day in the sur-
veillance period was 3,080, the CAUTI incidence density 
was 4.87 per 1,000 UC/day, and 80.0% of the patients 
who developed infection had no indication for UC use, 
while 86.7% had no prescription for insertion and/or 
maintenance. 
Table 1 – Descriptive analysis of the variables related to urinary 
catheter use in the intensive care unit – Montes Claros, MG, 
Brazil, June 2016 to July 2017.
Variables n (%)
Location of catheter insertion (n=402)
Surgical ward 170 (42.3)
Emergency ward 70 (17.4)
Intensive care unit 30 (7.5)
Infirmary 70 (17.4)
Other locations outside hospital units 62 (15.4)
Professional who inserted the catheter (n=402)
Nursing technician 283 (70.4)
Nurse 34 (8.5)
Doctor 15 (3.7)
No record 70 (17.4)
Prescription of catheter insertion (n=402)
Yes 52 (12.9)
No 350 (87.1)
Indication for use of the catheter (n=402)
Yes 78 (19.4)
No 324 (80.6)
Type of indication suitable for catheter use (n=78)
Presumed 78 (100)
Recorded 0 (0)
Description of the presumed indication for insertion of 
the catheter (n=78)
Patient underwent urological surgery 31 (39.7)
Patient immobilized due to trauma 19 (24.4)
Terminal patient to provide comfort 12 (15.4)
Incontinent patients with sacral or perineal ulcers 6 (7.7)
Patient with inability to spontaneously urinate 5 (6.4)
Long-term surgery 5 (6.4)
Urinalysis performed (n=402)
Yes 141 (35.1)
No 261 (64.9)
Result of the urinalysis (n=141)
Positive 25 (17.7)
Negative 116 (82.3)
Microorganism identified in urinalysis of the catheter 
(n=25)
Klebsiella pneumoniae 10 (40.0)
Escherichia coli 4 (16.0)
Pseudomonas aeruginosa 3 (12.0)
Acinetobacter baumannii 2 (8.0)
Enterococcus SP 1 (4.0)
Others 5 (20.0)
Multiresistant microrganisms (n=25)
Yes 9 (36.0)
No 16 (64.0)
Diagnosis of catheter-associated urinary tract infection 
(n=402)
Yes 15 (3.7)
No 387 (96.3)
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Of the 141 patients who performed urinalysis, 70.9% 
had previously used antibiotics for at least 24 hours in the 
ICU. Regarding the CAUTI etiological agent, Klebsiella 
pneumoniae (46.7%), Escherichia coli (20.0%), Pseudomonas 
aeruginosa (13.3%), Acinetobacter baumannii (13.3%) and 
Enterococcus sp (6.7%) were identified. All multiresistant 
microorganisms identified in urinalysis were associated with 
CAUTI, namely: K. pneumoniae (44.5%), E. coli (22.2%), 
P. aeruginosa (11.1%), A. baumannii (11.1%) and 
Enterococcus sp (11.1%). Table 2 shows the comparison of 
the patients regarding the CAUTI diagnosis according to 
sociodemographic and clinical factors.
Table 2 – Comparison of sociodemographic and clinical factors 
of patients admitted to the intensive care unit with and without 
urinary tract infection diagnosis – Montes Claros, MG, Brazil, 
from June 2016 to July 2017.
Variables
Catheter-associated 
Urinary Tract 
Infection P-Value
Yes
n (%)
No 
n (%)
Gender
Female 7 (4.0) 167 (96.0) 0.788*
Male 8 (3.5) 220 (96.5)
Age range, years
<60 9 (3.3) 263 (96.7) 0.518*
≥60 6 (4.6) 124 (95.4)
Location of catheter insertion
Surgical ward 9 (5.3) 161 (94.7) 0.228†
Emergency ward 4 (5.7) 66 (94.3)
Intensive care unit 0 (0) 30 (100)
Infirmary 2 (2.9) 68 (97.1)
Other locations outside hospital 
units 0 (0) 62 (100)
Length of stay in the intensive care unit, days
Mean ± standard deviation 16.7±9.0 7.7±8.5 <0.001‡
Median 16 (4-32) 5 (1-68)
Hospitalization time, days
Mean ± standard deviation 75.8±68.6 28.2±30.6 0.001‡
Median 33 (7-242) 19 (1-222)
Catheter permanence time, days
Mean ± standard deviation 12.7±6.9 6.9±7.3 <0.001‡
Median 12 (4-30) 4 (1-68)
Indication for use of the catheter
Yes 3 (3.8) 95 (96.2) 0.583†
No 12 (3.7) 312 (96.3)
Use of antimicrobials in the intensive care unit
Yes 14 (4.0) 337 (96.0) 0.411†
No 1 (2.0) 50 (98.0)
Days of antimicrobial use in the intensive care unit
Mean ± standard deviation 8.6±6.3 5.2±6.1 0.019†
Median 9 (1-21) 3 (1-59)
Death
Yes 2 (1.4) 142 (98.6) 0.09†
No 13 (5.0) 245 (95.0)
*Chi-squared test; †Fisher’s exact test; ‡Mann-Whitney test.
Note: (n=402).
The UC duration was significantly associated with 
CAUTI. Figure 1 shows this relationship.
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Figure 1 – Relationship between catheter retention time and 
catheter-associated urinary tract infection in patients admitted 
to the intensive care unit – Montes Claros, MG, Brazil, from June 
2016 to July 2017.
The mean time between UC insertion and CAUTI diag-
nosis was 11.3 days (median: 8), with a standard deviation 
of ± 6.3 (minimum of 6 and maximum of 28 days), and 
mean time between ICU hospitalization and the CAUTI 
diagnosis was 9.6 days (median: 7), with a standard deviation 
of ± 5.6 (minimum of 4 and maximum of 26 days). 
Although no significant difference was observed between 
the permanence time of the UC according to the inser-
tion location (p > 0.05), the catheters inserted in the infir-
mary wards/apartments had a longer residence time (mean 
9.8 ± 10.5; median of 7, minimum of 1 and maximum of 68 
days), compared to those inserted in the surgical ward (mean 
5.7 ± 6, median of 3, minimum of 1 and maximum of 32 days). 
DISCUSSION
Urinary catheter use was considered inappropriate in 
80.6% in relation to the indication and the evaluation of the 
necessity of its permanence. The CAUTI incidence density 
in the present study is within the range registered by the 
National Health Surveillance Agency (ANVISA – Agência 
Nacional de Vigilância Sanitária), which refers to indices of 
3.1 to 7.4/1000 catheters/day(8). It should be considered 
that this rate may be underestimated even according to the 
intervals defined by ANVISA. This possibility is based on 
the fact that the criterion for defining CAUTI used in this 
study considers a positive urinalysis, a procedure registered in 
35.1% of patients with UC, as well as clinical signs. Another 
interesting fact is that even though urinalysis was performed, 
a large part (70.9%) of these patients used antibiotics prior 
to urinalysis, which certainly hinders the growth of micro-
organisms and provides false-negative results. 
Although the CAUTI rate in the present study is compa-
rable to the national data, it is higher when compared to records 
of international organizations. In a multicenter ICU study from 
50 countries, The International Nosocomial Infection Control 
Consortium (INICC) recorded CAUTI incidence density of 
3.9 per 1,000 catheters/day, and this rate was even lower (1.7 
per 1,000 catheters/day) in ICUs of American hospitals in 
the CDC-NHSN report. The difference found between these 
two reports is associated to the possibility of its variation being 
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related to the socioeconomic level of the country and to the 
experience in infection control and patient safety, which can 
strongly influence the CAUTI indicators(11-12).
Regarding the sociodemographic and clinical factors of 
the patient which may increase the risk of CAUTI, advanced 
age and female gender are considered groups with higher 
predisposition(2,13). However, the CAUTI rates in this study 
were associated with clinical factors such as the UC perma-
nence time and the patient’s time in the ICU.
Most UCs were inserted by nursing technicians and 
without prescription and/or indication; when there was the 
indication, all were presumed by the researcher. Although 
the data point to the contrary of what is disseminated as a 
need for accurate and restricted indication of UC use, sev-
eral studies corroborate this scenario in which catheters are 
often inserted without proper indication, and once inserted 
they are not reevaluated in time for them to be removed(4-6). 
It should also be pointed out that the adequate indication 
for UC should be considered as the first step in CAUTI 
prevention, and that the risk of this adverse event (mostly 
avoidable) already shows greater probability of occurrence 
when this barrier is exceeded(2,5-7). 
After adequate indication, or lack of it, relevant CAUTI 
prevention and control mechanisms should still be observed 
daily, thereby highlighting the next aspect which refers to 
the UC duration. It should be evaluated in accordance with 
international recommendations, so that it remains in place 
for as short of a time as possible. 
The majority of insertions performed in surgical patients 
did not have adequate indications (72.9%), and the UC 
duration (mean of 5.7 days) was higher than indicated by 
the guidelines, which recommend the use of this device in 
specific surgeries and their removal as soon as possible post-
operatively, preferably within 24 hours, unless there are other 
appropriate indications for their permanence(2,7-12).
It is also important to evaluate the insertion conditions 
of the UC, especially in emergencies such as in the surgical 
ward, the emergency room and pre-hospital care. Although 
UC replacement at fixed intervals is not recommended, and 
the unit investigated does not have a UC exchange protocol 
inserted in emergency situations, the guidelines recommend 
this practice when there are failures in aseptic technique, 
disconnection or leakage, obstruction or if the system drain-
age system is compromised(2,7).
In this sense, it is also important to highlight the actions 
necessary to reduce inappropriate use in terms of UC dura-
tion, how to recognize and notify its presence in the patient, 
to discuss the need for their maintenance with the medi-
cal staff daily and ensure prescription for its removal. Such 
actions have not been observed in clinical practice, and the 
result is maintaining high CAUTI rates caused by failures 
in multiprofessional care actions and ineffective commu-
nication resulting from the poor quality of the records. 
Studies point out that the catheter presence in the patient 
is unknown, inadequate practices, unsafe maintenance, lack 
of control and attention to the need for their permanence 
by the multiprofessional team as factors which drive the 
occurrence of CAUTI(4-6).
Thus, nursing performance should play an important role 
in daily evaluation of UC permanence. The implementa-
tion of a nurse-oriented protocol effectively reduces CAUTI 
prevalence, and it is essential that these professionals feel 
empowered to (re)evaluate and discuss the need to maintain 
the UC, aiming at reducing their usage time(14). The quality 
of CAUTI care and prevention programs is directly related 
to the adequate number of professionals to exercise care in 
order to promote safe care(6,15). In the studied unit, the num-
ber of nursing professionals complies with the resolution of 
the Federal Nursing Council (COFEN – Conselho Federal 
de Enfermagem) for care provided to intensive care patients, 
not constituting a barrier in this process.
It is also worth noting that the insertion of the UC, 
defined by the normative opinion of COFEN, “is an activity 
that requires trained and qualified professionals because it 
is an invasive procedure which involves risks to the patient.” 
Also, “it requires care of greater technical complexity and 
scientific knowledge, and for these reasons UC insertion is 
exclusively performed by the nurse in the scope of the nurs-
ing team”, which reinforces its participation in the evaluation 
from its indication to the daily maintenance, as well as in 
the adopted practices in their handling(6,16).
Guidelines for CAUTI prevention emphasize that the 
most effective and economic measures are to limit the use 
of urinary catheters to patients with clear indication and to 
remove them as soon as they are no longer needed(2,7-8). The 
median time between UC insertion and CAUTI occur-
rence in this study was 8 days. Approximately 50.0% of the 
catheterized patients acquire infections after a short period 
of time (within 7 days), and the infection is practically inevi-
table after 28 days(3).
After UC insertion, the bacteria that colonize the ure-
thral meatus adhere to the internal and/or external surface 
of the catheter and can initiate biofilm formation, considered 
the most important factor for CAUTI. Thus, in addition to 
catheter removal, there is no evidence of effective methods 
for prevention or control of biofilm formation(17-19).
The main microorganisms which caused CAUTI in this 
investigation were the Gram-negative microorganisms such 
as K. pneumoniae and E. coli, identified as the most common 
etiological agents. The high prevalence of these bacteria is 
due to their motility, facilitating their ascension via intra- 
or extraluminal of the UC(1,13). In addition to E. coli, other 
microorganisms are strongly associated with CAUTI, such 
as Enterococcus spp, P. aeruginosa, Proteus mirabilis, K. pneu-
moniae and Enterobacter sp.(6). 
An important factor which aggravates the etiology of 
CAUTI is bacterial resistance. In this study, all multiresis-
tant microorganisms identified in urinalysis were associated 
with CAUTI. Intensive care unit patients are at high risk for 
CAUTI caused by resistant bacteria, as many have changes 
in their immune system and receive broad spectrum antimi-
crobials, in addition to UC being an important reservoir of 
multiresistant microorganisms, causing serious infections, pro-
longed hospitalizations, high costs and higher mortality(3,17).
Multiple-measure strategies have been pointed out as being 
possible to reduce the occurrence of CAUTIs when adopted 
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simultaneously. However, their implementation requires changes 
which usually involve education, leadership commitment, and 
implementation of guidelines for indication and appropriate 
UC use(1,5,18,20-21). Guaranteeing that all health care team mem-
bers are aware that a patient has a UC is an important strategy 
for reducing CAUTI and ensuring quality in maintenance care 
and a daily assessment of their permanence(20-21).
Regarding the evaluation of the records adopted in this 
study (the electronic records analysis), it is known that there 
may be an absence of information due to the lack of records 
by the professionals and the quality of the records, as well as 
physical records which also present these limitations.
CONCLUSION
The factors which were significantly associated to 
CAUTI were the length of hospital stay in the ICU and in 
the hospital, UC permanence time, and days of antimicrobial 
use in the ICU. The urinary catheter use was associated with 
high rates of urinary tract infections, but without indications 
and records justifying its use. All appropriate indications 
for UC use were presumed, which is an important indica-
tor of failure in the work process not being systematized in 
terms of documentation, therefore posing a potential risk 
to patient safety.
RESUMO
Objetivo: Identificar fatores relacionados à ocorrência de infecção do trato urinário associada ao uso do cateter vesical. Método: 
Estudo longitudinal, coorte retrospectivo, realizado pela análise do prontuário eletrônico de pacientes admitidos em unidade de terapia 
intensiva de um hospital de alta complexidade, de julho de 2016 a junho de 2017. Avaliaram-se dados demográficos e clínicos, por 
análise descritiva e analítica. Resultados: A densidade de incidência da infecção urinária relacionada ao uso do cateter vesical foi 
de 4,8 por 1.000 cateter/dia, sendo a maioria (80,6%) sem indicação para uso do cateter e, em 86,7%, não havia prescrição para 
inserção e/ou manutenção. O tempo médio entre inserção do cateter vesical e diagnóstico de infecção foi de 11,3±6,3 dias (6 a 28 dias). 
Os fatores estatisticamente significativos (p<0,001) relacionados à infecção urinária relacionada ao uso do cateter vesical foram tempo 
de internação na unidade (16,7±9 dias), tempo de permanência do cateter vesical (12,7±6,9 dias) e uso de antimicrobianos na unidade 
de terapia intensiva (8,6±6,3 dias). Conclusão: A associação da ausência da indicação e do registro da necessidade de manutenção 
possivelmente potencializou a ocorrência de infecção urinária relacionada ao uso do cateter vesical. 
DESCRITORES
Cateteres Urinários; Infecções Relacionadas a Cateter; Segurança do Paciente; Controle de Infecções.
RESUMEN
Objetivo: Identificar factores relacionados con la ocurrencia de infección del tracto urinario asociado con el uso del catéter vesical. 
Método: Estudio longitudinal, de cohorte retrospectivo, realizado por análisis de la ficha electrónica de pacientes ingresados en unidad 
de cuidados intensivos de un hospital de alta complejidad, de julio de 2016 a junio de 2017. Se evaluaron los datos demográficos y 
clínicos, por análisis descriptivo y analítico. Resultados: La densidad de incidencia de la infección urinaria relacionada con el uso del 
catéter vesical fue de 4,8 por 1.000 catéter/día, siendo la mayoría (80,6%) sin indicación para uso del catéter y, en el 86,7%, no había 
prescripción para inserción y/o mantenimiento. El tiempo medio entre inserción del catéter vesical y diagnóstico de infección fue de 
111,3±6,3 días (6 a 28 días). Los factores estadísticamente significativos (p<0,001) relacionados con la infección urinaria relacionada 
con el uso del catéter vesical fueron tiempo de estancia hospitalaria en la unidad (12,7±6,9 días) y uso de antimicrobianos en la unidad 
de cuidados intensivos (8,6±6,3 días). Conclusión: La asociación de la ausencia de la indicación y del registro de la necesidad de 
mantenimiento posiblemente potenció la ocurrencia de infección urinaria relacionada con el uso del catéter vesical.
DESCRIPTORES
Catéteres Urinarios; Infecciones Relacionadas con Catéteres; Seguridad del Paciente; Control de Infecciones.
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